Современные возможности лечения токсического зоба в регионе зобной эндемии



Скачать 11.62 Mb.
страница14/15
Дата30.04.2016
Размер11.62 Mb.
ТипДиссертация
1   ...   7   8   9   10   11   12   13   14   15

164

Ardito G., Mantovani M., Vincenzoni C., Guidi M.L., Corsello S., Rabitti C., Fadda G., Di Giovanni V. Hyperthyroidism and carcinoma of the thyroid gland // Аnn. Ital. Chir. 1997. V. 68(1). P. 23-27.

165

Arslan H., Unal O., Algün E., Harman M., Sakarya M.E. Power Doppler sonography in the diagnosis of Graves' disease // Eur. J. Ultrasound. 2000 May. V. 11(2). P.117-22.

166

Baek H.J. Radiofrequency ablation therapy (RFAT) for benign thyroid nodules: the efficacy, safety, and factors affecting the results of treatment. Oral presentation // Abstracts of the 93rd Scientific Assembly and annual meeting of the Radiologic Society of North America. 2008.

167

Baek J.H., Moon W.J., Kim Y.S., Lee J.H., Lee D. Radiofrequency ablation for the treatment of autonomously function in thyroid nodules // World J. Surg. 2009. V.33 (9). P.1971-1977.

168

Baloch Z.W., Fleisher S., Livoski V.A. [et al.] Diagnosis of “follicular neoplasm” a grey zone in thyroid fine needle aspiration cytology // Diagn. Cytopathol. 2002. V. 26. P. 41-44.

169

Barakate M.S., Agarwal G., Reeve T.S. [et al.] Total thyroidectomy is now a preferred option for surgical management of Graves’ disease // ANZ. J. Surg. 2002. V.72 (5). P. 321-324.

170

Barclay L. Ethanol ablation safe, effective method for thyroid cystic nodules. Medscape Medical News. 2003.

171

Bartalena L. The dilemma of how to manage Graves hyperthyroidism in patients with associated orbitopathy // J. Clin. Endocrinol. Metab. 2011. V. 96. P. 592–599.

172

Bartos M., Kuzdak K., Kukulsky K., Narebsky J., Pomorsky L. Treatment of solitary toxic thyroid nodules with the use of percutaneous ethanol injections // Wiad. Lek. 2000. V. 53, N 1-2. P. 22-29.

173

Belfiore A., Garofalo M.R., Giuffrida D., Runello F., Filetti S., Fiumara A. [et al.] Increased aggressiveness of thyroid cancer in patients with Graves’ disease // J. Clin. Endocrinol. Metab. 1990. V. 70. P. 830–835.

174

Bielecka-Dabrowa A., Mikhailidis D.P., Rysz J., Banach M. The mechanisms of atrial fibrillation in hyperthyroidism // Thyroid Res. 2009. N 2. P. 4.

175

Biondi B., Kahaly G.J. Cardiovascular involvement in patients with different causes of hyperthyroidism // Nat. Rev. Endocrinol. 2010. N 8. P. 431–443.

176

Biondi B. Invited commentary: cardiovascular mortality in subclinical hyperthyroidism: an ongoing dilemma // Eur. J. Endocrinol. 2010. V. 162. P. 587–589.

177

Bitterman A., Uri O., Levanon A., Baron E., Lefel O., Cohen O. Thyroid carcinoma presenting as a hot nodule // Otolaryngol. Head, Neck Surg. 2006. V. 134 (5). P. 888-889.

178

Bojarska-Szmygin A., Ciechanek R., Jezierska B., Zaorska-Rajca. Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases // Pol. Merkur. Lekarski. 2002. V. 13(75). P. 196-199.

179

Brandt F, Green A, Hegedüs L, Brix TH. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality // Eur. J. Endocrinol. 2011. V. 165. P. 491–497.

180

Brkjicic B., Sucic M., Borikov V. [et al.] Treatment of autonomous and toxic thyroid adenomas by percutaneous ultrasound-guided ethanol injections // Acta Radiol. 2001. V. 42(5). P. 321-324.

181

Brona A., Bohdanowicz-Pawlak A., Jdrzejuk D., Milewicz A. Fibrinogen and D-dimmers levels in patients with hyperthyroidism before and after radioiodine therapy // Endokrynologia Polska. 2011. V. 62(5). P. 409–415.

182

Bubnov A.N., Kuzmichev A.S., Fedotov Yu.N. Management of nodular thyroid goiter // Symposium on Endocrine Surgery. 2003. S-Petersburg. P. 23-34.

183

Bulow P.I., Laurberg P., Knudsen N. [et al.] Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark // J. Clin. Endocrinol. Metab. 2006. V. 91. P. 3830–3834.

184

Calò P.G., Pisano G., Medas F., Tatti A., Tuveri M., Nicolosi A. Risk factors in reoperative thyroid surgery for recurrent goiter: our experience // G. Chir. 2012. V. 33(10). P. 335-338.

185

Cappeli C., Pirola I., De Martino E. [et al.] The role of the imagining in Graves disease: A cost-effectiveness analysis // Eur. J. Radiol. 2008. V. 65(1). P. 99-103.

186

Cappelli C., Braga M., De Martino E., Castellano M., Gandossi E., Agosti B. [et al.] Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy // Surgery Today. 2006. V. 36. P. 25–30.

187

Cappola A.R., Fried L.P., Arnold A.M. [et al.] Thyroid status, cardiovascular risk, and mortality in older adults // JAMA. 2006. V. 295(9). P. 1033–1041.

188

Carlé A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, Rasmussen LB, Laurberg P. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study // Eur. J. Endocrinol. 2013. V. 169(5). P. 537-545.

189

Carneiro-Ramos M.S., Dinis G.P., Nadu A.P. [et al.] Blockage of angiotensin-II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking // Cardiol. 2010. V. 105. P. 325–335.

190

Carty S.E., Cooper D.S., Doherty G.M., Duh Q.Y., Kloos R.T., Mandel S.J., [et al.] Consensus statement on the terminology and classification of central neck dissection for thyroid cancer // Thyroid. 2009. V. 19. P. 1053–1058.

191

Cashman E.C., Bresnihan M., Timon C. Patients' quality of life post thyroidectomy // B-ENT. 2011. V. 7(4). P. 261-265.

192

Cesur M., Corapcioglu D., Bulut S., Gursoy A., Yilmaz A.E., Erdogan N., Kamel N. Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules // Thyroid. 2006. V. 16(6). P. 555-561.

193

Chen W.J., Yeh Y.H., Lin K.H., Chang G.J., Kuo C.T. Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism // Cardiol. 2011. V. 106. P. 163–174.

194

Chianelli M., Bizzarri G., Todino V., Misischi I., Bianchini A., Graziano F., Guglielmi R., Pacella C.M., Gharib H., Papini E. Lazer ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter // J. Clin. Endocrinol. Metab. 2014. V. 201, N 3. 59-67.

195

Chisholm E.J., Kulinskaya E., Tolley N.S. Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone // Laryngoscope. 2009. V. 119. P. 1135–1139.

196

Chow T.L., Chu W., Lim B.H., Kwok S.P. Outcomes and complications of thyroid surgery: retrospective study // Hong Kong Med. J. 2001.V. 7(3). P. 261-265.

197

Coban E., Aydemir M., Yazicioglu G., Ozdogan M. Endothelial dysfunction in subjects with subclinical hyperthyroidism // Journal of Endocrinological Investigation. 2006. V. 29(3). P. 197–200.

198

Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J. [et al.] Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer // Thyroid. 2009. V. 19. P. 1167–214.

199

Dahl P., Danzi S., Klein I. Thyrotoxic cardiac disease // Cur. Heart Fail. Res. 2008. V. 5. P. 170–176.

200

Dănciulescu Miulescu R., Carşote M., Trifănescu R., Ferechide D., Poiană C. Antithyroid drugs induced agranulocytosis and multiple myeloma: case report and general considerations // J. Med. Life. 2013. V. 6(3). P. 327-31.

201

de Rooij A., Vandenbroucke J.P., Smit J.W., Stokkel M.P., Dekkers O.M. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis. // Eur. J. Endocrinol. 2009. V. 161(5). P. 771–777.

202

De Vos R.J., Bouvy N.D., Bonjer H.J. [et al.] // Fine needle aspiration cytology of thyroid nodules; how accurate is it? // Cytopathology. 2001. V. 12. P. 399-405.

203

Del Prete, Russo D., Caraglia M. [et al.] Percutaneous ethanol injection of autonomous thyroid nodules with volume larger than 40 ml; three years follow-up // Clin.Radiol. 2001. V. 56(11). P. 895-901.

204

Delange F., Benker G., Caron Ph. [et al.] Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency //European Journal of Endocrinology. 1997. V. 136. P. 180-187.

205

Dörr M., Wolff B., Robinson D.M. [et al.] The association of thyroid function with cardiac mass and left ventricular hypertrophy // The Journal of Clinical Endocrinology and Metabolism. 2005. V. 90(2). P. 673–677.

206

Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy // Surgery. 2001. V. 130(6). P. 971-7.

207

Enomoto K., Uchino S., Watanabe S., Enomoto Y., Noguchi S. Recurrent laryngeal nerve palsy during surgery for benign thyroid diseases: risk factors and outcome analysis // Surgery. 2014. V. 155(3). P. 522-528.

208

Erbil Y., Bozbora A., Yanik B.T., Ozbey N., Salmaslioğlu A., Ozarmağan S. Predictive factors for recurrent non-toxic goiter in an endemic region // J. Laryngol. Otol. 2007. V. 121(3). P. 231-236.

209

Erem C. Thyroid disorders and hyper coagulability. Seminars in Thrombosis and Hemostasis. 2011. V. 37(1). P. 17–26.

210

Ertek S., Cicero A.F. Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology // Arch. Med. Sci. 2013 V. 9(5). P. 944-952.

211

Fay W.P., Garg N., Sunkar M. Vascular functions of the plasminogen activation system // Arteriosclerosis, Thrombosis, and Vascular Biology. 2007. V. 27(6). P. 1231-1237.

212

Ferrara A. Therapeutic indications for autonomous adenoma of the thyroid: 71 cases // Ann. Ital. Chir. 2000. V. 71(2). P. 177-180.

213

Fisher J.N. Management of thyrotoxicosis // South. Med. J. 2002. V. 95(5). P. 493-505.

214

Franco M., Chavez E., Perez-Mendez O. Pleiotropic effects of thyroid hormones: learning from hypothyroidism // J. Thyroid Res. 2011. V. 3 (2). P. 1030.

215

Galetta F., Franzoni F., Fallahi P. [et al.] Changes in autonomic regulation and ventricular repolarisation induced by subclinical hyperthyroidism // Biomed. Pharmacol. 2010. V. 64. P. 546–559.

216

Ghandour A., Reust C. Hyperthyroidism: a stepwise approach to treatment // J. Fam. Pract. 2011. V. 60. P. 388–395.

217

Gimondo P., Pizzi C., Gimondo S., Messina G. Ultrasonography, with Doppler color, and cytological correlations in Plummer's disease // Radiol. Med. 1998. V. 95(3). P.193-198.

218

Giuffrida D., Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules // Am. J. Med. 1995. V. 99. N 6. P. 642-650.

219

Goldstein R.E., Netterville J.L., Burkey B. [et al.] // Implications of follicular neoplasms atypia, and lesions suspicious for malignancy diagnosed by fine needle aspiration of thyroid nodules // Ann. Surg. 2002. V. 235(5). P. 656-662.

220

Gu L.Q., Zhao L., Zhu W. [et al.] Relationships between serum levels of thyroid hormones and serum concentrations of symmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT- pro BNP) in patients with Graves’ disease // Endocrine. 2011. V. 39. P. 266–271.

221

Guntekin U., Gunes Y., Tuncer M. [et al.] QTc dispersion in hyperthyroidism and its association with pulmonary hypertension // Pacing Clin. Electrophysiol. 2009. V. 32. P. 494–499.

222

Gurgul E., Sowinski J. Primary hyperthyroidism--diagnosis and treatment. Indications and contraindications for radioiodine therapy // Nucl. Med. Rev. Cent. East Eur. 2011. V. 14(1). P. 29-32.

223

Haddad F., Jiang W., Bodell P.W., Qin A.X., Baldwin K.M. Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications // Am. J. Physiol. Heart Circ. Physiol. 2010. V. 299. P. 1968–1980.

224

Harada Y., Akiyama H., Yoshimoto T., Urao Y., Ryuzaki M., Handa M. Thyroid storm with multiple organ failure, disseminated intravascular coagulation, and stroke with a normal serum FT3 level // Intern Med. 2012. V. 51(17). P. 2379-2383.

225

Hari Kumar K.V., Pasupuleti V., Jaraman M. [et al.] Role of Thyroid Doppler in differential diagnosis of thyrotoxicosis // Endocr. Pract. 2009. V. 15(1). P. 6-9

226

Harreld J.H, Kilani R.K., Lascola C.D., Bartz S.K. MR imaging of fetal goiter // AJNR Am. J. Neuroradiol. 2011. V. 32(8). P. 160.

227

Hassan I., Danila R., Maurer E., Osei-Agymang T., Zielke A. Severe Graves’ ophthalmopathy may be a risk factor for the development of post thyroidectomy hypocalcaemia // Exp. Clin. Endocrinol. Diabetes. 2008. V. 116. P. 614–618.

228

Heeringa J., Hoogendoorn E.H., van der Deure W.M. [et al.] High-normal thyroid function and risk of atrial fibrillation: the Rotterdam Study // Arch. Intern. Med. 2008. V. 168. P. 2219–2224.

229

Hegedus L., Dossing H., Bennebaek S.N. Laser thermal ablation of benign thyroid nodules – indications, technique,, effects and side effects // Materials of International Scientific conference “Minimally invasive technologies in endocrine surgery”. P. 117-120. St. Petersburg. 2008.

230

Hiromatsu Y. [et al.] Increased serum soluble F as in patients with Graves' disease // Thyroid. 1999. V. 9(4). P. 341-345.

231

Huang S.M., Chow N.H., Lee H.L. [et al.] The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves’ disease // Arch. Surg. 2003. V. 138(2). P. 146-151

232

Hundhahl S.A., Cady B., Cunningham M.P. Initial results from prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 // Cancer (Cytopathol). 2000. V. 89. P. 202-217.

233

Jacobson E.M., Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH-receptor and PTPN 22 gene quintet and its contribution to thyroid autoimmunity: back to the future // J. Autoimmun. 2007. V. 28(2-3). P. 85-98.

234

Janowitz P., Ackmann S. Langzeitergebnisse der ultraschallgestenerten Alkoholinstillation bei Patienten mit focalen Shilddrusenautonomic und Hyperthyreose // Med. Klin. 2001. V. 96(8). P. 451-456.

235

Jiskra J., Kubinyi J., Telička Z. Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option // Vnitr Lek. 2012. 58(2). P. 94-98.

236

Kaminski G., Michalkiewicz D., Makowski K. [et al.] Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism // Clinical Endocrinology. 2011. V. 74(4). P. 501–507.

237

Kasturi S., Ismail-Beigi F. Effect of thyroid hormone on the distribution and activity of Na, K ATPase in ventricular myocardium // Arch. Biochem. Biophys. 2008. V. 475. P. 121–127.

238

Kasuga Y., Kobayashi S., Fujimori M., Shingu K., Asanuma K., Hama Y., Ito K., Maruyama M., Amano J. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease // Eur. J. Surg. 1998. V. 164(3). P. 173-178.

239

Kittisupamongkol W. Hyperthyroidism or thyrotoxicosis? // Clev. Clin. J. Med. 2009. V. 76(3). P. 152

240

Klima G., Rothlauer W. Sonography of the thyroid gland //Acta Med. Austriaca 2000. V. 27, N.2. P. 42-44.

241

Kostka A. Risk factors of early recurrence after surgical treatment in Graves disease // Folia Med. Cracov. 2004. V. 45(1-2). P. 97-119.

242

Kozlowski D., Budrejko S., Lip G.Y. [et al.] Dronedarone: an overview // Ann. Med. 2012. V. 44. P. 60–72.

243

Krohn K., Führer D., Bayer Y., Eszlinger M., Brauer V., Neumann S., Paschke R. Molecular pathogenesis of euthyroid and toxic multinodular goiter // Endocr. Rev. 2005. V. 26(4). P. 504-524.

244

Lacka K., Fraczek M. Classification and etiology of hyperthyroidism // Pol. Merkur. Lekarski. 2014. V. 36(213). P. 206-211.

245

Lefevre J.H., Tresallet C., Leenhardt L., Jublanc C., Chigot J.P., Menegaux F. Re-operative surgery for thyroid disease // Langenbecks Arch. Surg. 2007. V. 392. P. 685–691.

246

Liebert M.A. Thyroid fine needle aspiration (FNA) and cytology // Thyroid. 2003. V. 13(1). P. 80-86.

247

Liel Y., Barchana M. Long term follow-up of patients with initially benign fine needle aspirations // Thyroid. 2001. V. 11. P. 775-778.

248

Limonard E.J., Bisschop P.H., Fliers E., Nieveen van Dijkum E.J. Thyroid function after subtotal thyroidectomy in patients with Graves' hyperthyroidism // Scientific World Journal. 2012. V. 54. P. 87-96.

249

Lin H., Mitasikova M., Dlugosova K. [et al.] Thyroid hormones suppress epsilon PKC-signaling, down regulate connexin-43 and increase lethal arrhythmia susceptibility in non-diabetic and diabetic rats // J. Physiol. Pharm. 2008.V. 59. P. 271–285.

Каталог: files -> science -> comming protection
comming protection -> Терапия кардиоселективными β-адреноблокаторами нарушений ритма сердца у больных хобл пожилого и старческого возраста 14. 01. 04. внутренние болезни
comming protection -> Выбор метода лечения гнойного холангита при механической желтухе у лиц пожилого и старческого возраста 14. 01. 17 хирургия
comming protection -> В сети Интернет 06. 05. 2015г. Абдулхаликов Абдулхалик Салимханович современные возможности лечения токсического зоба в регионе зобной эндемии 14. 01. 17. хирургия

Скачать 11.62 Mb.

Поделитесь с Вашими друзьями:
1   ...   7   8   9   10   11   12   13   14   15




База данных защищена авторским правом ©zodorov.ru 2020
обратиться к администрации

    Главная страница